Filter
6358
Text search:
drug
use
Featured
Recommendations
571
New Publications
1586
Language
Document type
No document type
3682
Studies & Reports
992
Guidelines
848
Manuals
304
Strategic & Response Plan
191
Fact sheets
132
Training Material
97
Infographics
29
Situation Updates
28
Resource Platforms
20
Brochures
16
Online Courses
10
Videos
2
Dashboards/Maps
1
App
1
Countries / Regions
India
375
Global
208
Kenya
182
South Africa
158
Ethiopia
135
Uganda
134
Western and Central Europe
133
Nigeria
118
Tanzania
111
Nepal
107
Malawi
94
Sierra Leone
93
Liberia
92
Zambia
92
Africa
88
Latin America and the Carribbean
86
Myanmar / Burma
85
Bangladesh
80
Ghana
79
Ukraine
73
Eastern Europe
71
Rwanda
68
Namibia
64
Philippines
54
Russia
51
Zimbabwe
48
Asia
46
South–East Asia Region
42
Cambodia
40
Lesotho
38
Indonesia
32
Brazil
31
Botswana
31
Congo, Democratic Republic of
29
Syria
29
Mozambique
29
Eswatini/ Swaziland
24
Senegal
22
East and Southern Africa
22
Burkina Faso
21
Germany
21
West and Central Africa
19
Middle East and North Africa
19
Cameroon
17
Haiti
17
South Sudan
17
USA
16
Colombia
16
Eastern Europe and Central Asia
15
Venezuela
14
Albania
13
Tajikistan
13
Pakistan
12
Thailand
12
Guinea
11
China
11
Georgia
11
Vietnam
11
Afghanistan
10
Sudan
9
Benin
9
Argentina
9
Moldova
9
Paraguay
8
Laos
8
Peru
7
Sri Lanka
7
Chile
7
Yemen
7
Armenia
7
Mali
6
North Macedonia
6
Mexico
6
Western Pacific Region
6
North America
6
Somalia
5
Iraq
5
Jordan
5
Lebanon
5
Central African Republic
5
Ecuador
5
El Salvador
5
Spain
5
Turkey
4
Papua New Guinea
4
Bolivia
4
Libya
4
Angola
4
Bhutan
4
Timor Leste/ East Timor
4
Estonia
4
Iran
4
Jamaica
4
United Kingdom
4
Guinea-Bissau
3
Switzerland
3
Honduras
3
Madagascar
3
Fiji
3
Palestine
3
Uzbekistan
3
Kyrgyzstan
3
Uruguay
3
Belarus
3
Côte d’Ivoire / Ivory Coast
2
Morocco
2
Saudi Arabia
2
Chad
2
Serbia
2
Hungary
2
Guatemala
2
Nicaragua
2
Poland
2
Mongolia
2
Southern Africa
2
Canada
2
Romania
2
Kazakhstan
2
Gabon
2
Belgium
2
France
2
Portugal
2
Niger
1
Egypt
1
Gambia
1
Malaysia
1
Ireland
1
Singapore
1
Dominican Republic
1
Austria
1
Greece
1
Solomon Islands
1
North Korea
1
Italy
1
Congo-Brazzaville
1
Qatar
1
Bulgaria
1
Lithuania
1
Australia
1
Turkmenistan
1
Denmark
1
Maldives
1
Mauritius
1
Tunisia
1
Norway
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Authors & Publishers
Publication Years
Category
Countries
2397
Clinical Guidelines
549
Public Health
287
Women & Child Health
234
Key Resources
169
Capacity Building
105
Pharmacy & Technologies
77
Annual Report MEDBOX
1
Toolboxes
HIV
775
Mental Health
678
TB
576
AMR
315
COVID-19
304
NTDs
256
Pharmacy
201
NCDs
149
Caregiver
124
Malaria
112
Ebola & Marburg
94
Refugee
82
Rapid Response
76
Planetary Health
76
Conflict
67
Disability
66
Global Health Education
57
Health Financing Toolbox
49
2.0 Rapid Response
29
Cholera
25
Polio
25
Natural Hazards
23
Specific Hazards
22
Zika
21
Social Ethics
19
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
A tutorial for trainers in healthcare settings
Version 2: 2 Dec 2014
"The document focuses on an extended set of PPE components, which includes goggles, respirators, gloves,
coveralls and footwear. Used properly, these PPE components can provide effective protection even from airborne
transmissi
...
Cholera is an acute diarrhoeal disease caused by the ingestion of food or water contaminated with the bacterium V.
cholerae. It has a short incubation period of a few hours to 5 days. It is endemic in some countries, frequently
showing seasonal variations in the number of reported cases. Cholera a
...
A toolkit for pharmacists.
Emerging data show that medication errors and adverse events cause significant harm to patients’ health and
well-being. It is estimated that the burden of adverse events due to medicines is now comparable to that of
widespread diseases, such as malaria or tuberculosis
...
Research globally has shown that metered dose inhaler (MDI) technique is poor,
with patient education and regular demonstration critical in maintaining correct use of
inhalers. Patient information containing pictorial aids improves understanding o
...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
This chapter talks about how to safely use the medicines mentioned in the book to treat women’s health problems. It also provides information to help decide when to use medicines to improve women
...
Guideline ‒ Alternative mass drug administration regimens to eliminate lymphatic filariasis
recommended
Lymphatic filariasis is a vector-borne neglected tropical disease that causes damage of the lymphatic system and can lead to lymphoedema (elephantiasis) and hydrocele in infected individuals. The global baseline estimate of persons affected by lymphatic filariasis is 25 million men with hydrocele an
...
The infectious disease burden in India is among the highest in the world. A large amount of antibiot-ics are consumed in fighting infections, some of them saving lives, but every use adding to antibiotic resistance in bacteria. Antibiotic
...
Q12: Should the treatment be similar in individuals with intellectual disability and epilepsy compared to people with epilepsy only?
Africa Centers for Disease Control and Prevention (Africa CDC) is aware of the media releases of the preliminary results of a large randomized clinical trial conducted in the United Kingdom, which included dexamethasone, a corticosteroid, as one of the drugs used for the treatment of COVID-19 patien
...
23 December 2020 This document summarizes WHO recommendations for the rational use of personal protective equipment (PPE) in health care settings and temporary strategies during acute supply shortages. This document also contains 2 Annex sections de
...
Following review of evidence and advice from the Technical Advisory Group (TAG) on Tuberculosis (TB) Diagnostics and Laboratory Strengthening, the World Health Organization (WHO) announces that current WHO recommendations for the use of interferon-
...
Southern Med Review (2009)2;1:2-6
FDA’s compounding program aims to protect patients from unsafe, ineffective and poor quality compounded drugs, while preserving access to lawfully-marketed compounded drugs for patients who have a medical need for them. Here you can find informations to laws &policies, compliance action, ....